Add to Favorites Newsroom RSS Share
fb-shareLudwig Cancer Research
New York, NY USA

Our News on Newswise

ScreenShot2018-12-21at11.33.53AM.png

Heating Up Cold Tumors

A Ludwig Cancer Research study has uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies. Led by Ping-Chih Ho of the Lausanne Branch of the Ludwig Institute for...
21-Jan-2019 11:00 AM EST Add to Favorites

JohannaJoyceheadshot2017.jpeg

Johanna Joyce Appointed Member of Ludwig Institute for Cancer Research, Lausanne

Ludwig Cancer Research congratulates Johanna Joyce on her new role as Member of the Lausanne Branch of the Ludwig Institute for Cancer Research. Joyce will continue to lead her laboratory in exploring how non-cancerous cells within the tumor...
4-Oct-2018 9:00 AM EDT Add to Favorites

Davisdon.jpg

Nancy E. Davidson Joins Board of Directors for Ludwig Institute for Cancer Research

Ludwig Cancer Research is pleased to welcome Nancy E. Davidson to the Ludwig Institute Board of Directors. Nancy Davidson, a physician-scientist with extensive expertise in breast cancer research, is a leader in the cancer research community.
22-Aug-2018 9:00 AM EDT Add to Favorites

Ludwig Cancer Research and Cancer Research Institute Launch Clinical Trial Combining Virotherapy and Immunotherapy to Treat Advanced Colorectal and Ovarian Cancers

Ludwig Cancer Research and the Cancer Research Institute (CRI) announce the initiation of a clinical trial to evaluate the combination of ONCOS-102, an experimental anti-tumor virotherapy, with the checkpoint blockade antibody IMFINZI® (durvalumab)...
11-Jul-2018 12:00 PM EDT Add to Favorites

Ludwig-Developed Candidate Cancer Drug May Be Effective Against Broader Class of Brain Cancers

A Ludwig Cancer Research study explains why a particular mutation in the epidermal growth factor receptor (EGFR), a cell surface protein, results in more aggressive tumors and poorer overall survival of patients diagnosed with the brain cancer...
9-Jul-2018 4:15 PM EDT Add to Favorites

How Might Baking Soda Boost Cancer Therapy?

A Ludwig Cancer Research study has uncovered an entirely novel mechanism by which cells enter a state of dormancy as tissues starved of oxygen become increasingly acidic. The study, led by Chi Van Dang, scientific director of the Ludwig Institute...
25-May-2018 12:00 PM EDT Add to Favorites

ASCO to Honor Ludwig Scientists at 2018 Annual Meeting

The American Society of Clinical Oncology (ASCO) will honor two Ludwig scientists at its 2018 Annual Meeting in Chicago, Ill., June 1-5, 2018.
30-May-2018 9:00 AM EDT Add to Favorites

Ludwig Scientists Share New Findings on Personalized Cancer Treatments, Immunotherapy and the Tumor Microenvironment at 2018 AACR Annual Meeting

Ludwig Cancer Research released today the full scope of findings to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Chicago, Ill., April 14-18, 2018. Research conducted by more...
11-Apr-2018 4:00 PM EDT Add to Favorites


see all news

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Contacts

Emily Akpan
Junior Account Executive

emily@gga.nyc

347-728-2910

Sara Cott
Senior Account Executive

sara@globalgatewayadvisors.com

Carol Harrison
Senior Partner
cancer medicine

carol@gga.nyc

917-860-9499

Rachel Steinhardt
Vice President for Communications
cancer medicine

rsteinhardt@licr.org

212-450-1582

Our Multimedia on Newswise

Twitter twitter-icon

Chat now!